The board of directors of Shukra Pharmaceuticals Limited at its meeting held on May 29, 2023, Recommendation of final dividend of 5% (INR 0.50 per equity share of INR 10 each face value) for the financial year 2023 subject to the approval of shareholders in the upcoming annual general meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105 INR | -1.96% |
|
-9.49% | +239.23% |
1st Jan change | Capi. | |
---|---|---|
+239.23% | 56.16M | |
+21.80% | 43.81B | |
+30.40% | 23.03B | |
+19.84% | 15.45B | |
+19.05% | 14.4B | |
+58.92% | 12.95B | |
-0.05% | 6.79B | |
-11.84% | 6.49B | |
-8.87% | 5.73B | |
+13.00% | 5.49B |
- Stock Market
- Equities
- SHUKRAPHAR6 Stock
- News Shukra Pharmaceuticals Limited
- Shukra Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2023